What Is Stage 2 Endometriosis? Symptoms & Treatment

Stage 2 endometriosis, classified as “mild” under the most widely used scoring system, involves superficial implants and small areas of scarring on the pelvic lining, scoring between 6 and 15 points on the revised American Society for Reproductive Medicine (rASRM) scale.¹ The word “mild” is misleading, though, because the pain and disruption it causes can be anything but. The relationship between stage number and lived experience is far more complicated than a simple ladder from mild to severe, and the treatment landscape reflects that complexity.

How Staging Works and What It Actually Measures

The rASRM staging system assigns points based on the location, size, and depth of endometriotic implants, along with any adhesions found during surgery. Stage 1 (minimal) covers 1 to 5 points, Stage 2 (mild) covers 6 to 15, Stage 3 (moderate) runs from 16 to 40, and Stage 4 (severe) is anything above 40.¹ What this system captures well is the physical extent of visible disease. What it captures poorly is how much that disease hurts, how it affects fertility, or how much it interferes with daily life. This gap between what the staging system measures and what patients care about is probably the single most important thing to understand about a Stage 2 diagnosis.

The score itself comes from a surgical assessment, typically a laparoscopy. A surgeon examines the pelvis under direct visualization, tallies up what they see, and assigns a number. Two women can both land in Stage 2 with very different distributions of disease: one might have a handful of small implants scattered across the peritoneum, while another has fewer implants but some filmy adhesions pulling structures slightly out of place. Both score between 6 and 15, but their symptoms and treatment paths may diverge.

Why Pain Does Not Match the Stage Number

One of the most frustrating realities of endometriosis is that the severity of pain has little to do with how advanced the disease looks under a microscope or a camera. A systematic review and meta-analysis covering multiple studies found that pain intensity did not differ significantly between Stage 1/2 disease and Stage 3/4 disease.² Earlier research reached the same conclusion: no correlation between rASRM stage and the severity of chronic pelvic pain.³ In practical terms, someone with Stage 2 can be in as much pain as someone with Stage 4.

A study that broke down pain types by stage found that among women with Stage 2, severe menstrual pain (dysmenorrhea) was the most common presentation, affecting about 70% of those assessed. Chronic pelvic pain was present in all of them, roughly split between minimal and moderate intensity. Pain during sex (dyspareunia) was more variable, ranging from minimal to severe.⁴ The takeaway is that Stage 2 is not a guarantee of lighter symptoms. For many people, it still means debilitating periods, persistent pelvic discomfort, and pain that intrudes on sex and everyday activities.

The disconnect between stage and pain may come down to where implants land, how deeply nerves are involved, and the degree of inflammatory signaling in the pelvis, none of which the staging system captures precisely. In women with Stage 1 or 2 disease, the severity of deep pain during sex has been linked to bladder and pelvic floor tenderness rather than to endometriosis-specific factors alone.⁵ This suggests that what makes “mild” endometriosis painful often involves the surrounding tissues and their sensitivity, not just the implants themselves.

Getting to a Diagnosis

Historically, laparoscopy has been considered the gold standard for diagnosing endometriosis and assigning a stage. A surgeon looks directly at the pelvic surfaces, biopsies suspicious areas, and counts up the points. But even this approach has limitations. In one retrospective study, only about 75% of tissue samples excised during laparoscopy were confirmed as endometriosis by a pathologist, and the accuracy depended on the lesion site and the stage of disease.⁶ So even the “best” diagnostic tool overestimates the disease in roughly a quarter of cases.

Non-invasive imaging has improved but still struggles with Stage 2 disease specifically. Standard transvaginal ultrasound and MRI have traditionally been poor at spotting superficial peritoneal implants, the kind most common in Stage 2. MRI in one study detected fewer lesions than either laparoscopy or tissue analysis.⁷ A newer ultrasound technique that instills saline into the pelvic cavity to improve visualization of superficial lesions shows promise, but larger studies are still needed before it becomes standard practice.⁸

These diagnostic gaps help explain why endometriosis takes so long to identify. People with milder-stage disease often face the longest diagnostic delays, in part because imaging is less likely to show anything and symptoms get attributed to other causes. Healthcare costs climb during the delay period: one study found that pre-diagnosis costs roughly doubled when comparing short versus long delays, driven by repeated emergency and outpatient visits as people look for answers.⁹ As pain severity increases, so does the annual cost burden, which reflects how consuming the search for a diagnosis can be.¹⁰

Medical Treatment Options

Treatment for Stage 2 endometriosis usually begins with medication, especially if surgery is not immediately needed for fertility or severe symptoms that are not responding to anything else. The goals are straightforward: reduce pain, suppress the growth of implants, and improve quality of life.

Combined oral contraceptives are typically the first-line option. They work by suppressing ovulation and thinning the uterine lining, which reduces the production of inflammatory chemicals that drive menstrual pain. Using them continuously rather than in the standard monthly cycle tends to be more effective, and many people on this approach stop having periods altogether, which is the point.¹¹ The limitation is that oral contraceptives work better for period-related cramps than for other pain types, including pain during sex.

Progestins are another common choice and can be delivered by pill, injection, or an intrauterine device. A meta-analysis found that progestins significantly improved pain compared to placebo, with a relatively low rate of people quitting due to side effects.¹² Oral contraceptives and progestins together cover the ground for most people with Stage 2 disease, though it sometimes takes trying multiple options before finding one that balances symptom control against tolerable side effects.

For people who do not respond to first-line hormonal therapies, newer options exist. GnRH antagonists, such as elagolix, can reduce all three major pain types: period pain, non-menstrual pelvic pain, and pain during sex. Clinical evidence shows they improve quality of life and reduce the need for rescue painkillers, with less pronounced bone-loss and menopausal side effects compared to older GnRH agonist drugs.¹³ These medications typically come with time limits on use, though, because of their effects on bone density over the long term.

Surgery for Stage 2 Disease

When medications are not enough or when fertility is the goal, surgery enters the conversation. For Stage 2, the debate has centered on whether to excise (cut out) implants or ablate (burn) them. A meta-analysis found that excision produced better outcomes for menstrual pain and painful bowel movements compared to ablation at 12 months, along with greater reduction in chronic pelvic pain.¹⁴

However, another meta-analysis that specifically focused on minimal to mild disease found no significant difference between excision and ablation across any pain measure at 12 months or beyond.¹⁵ A randomized trial of the two approaches in mild endometriosis specifically reported that both produced good pain relief, with about two-thirds of participants experiencing meaningful improvement.¹⁶

The picture that emerges is that for Stage 2, both surgical techniques work reasonably well, and the difference between them matters more as disease severity climbs. Your surgeon’s experience and the specific location of your implants probably matter more than which technique gets used. One thing worth knowing: excision provides a tissue sample for pathology, which can confirm the diagnosis. Ablation destroys the tissue in place, so you lose that confirmation step.

Fertility and Stage 2 Endometriosis

Endometriosis at any stage can affect the ability to conceive, but the mechanisms in mild disease are subtler and less well understood than in advanced stages where anatomy gets distorted by large cysts or dense adhesions. In minimal and mild endometriosis, the problem appears to be driven more by the inflammatory environment in the pelvis than by structural damage. The peritoneal fluid of women with endometriosis contains elevated levels of immune cells and inflammatory chemicals, and because the reproductive organs sit in that fluid, these molecules can affect egg quality, embryo implantation, and even sperm function.¹⁷ The inflammatory cascade can also interfere with hormonal signaling and the receptivity of the uterine lining.¹⁸

The encouraging news is that pregnancy rates after surgery tend to be higher for Stage 1 and 2 disease than for more advanced stages.¹⁹ In one retrospective study of women with advanced endometriosis who underwent surgery, half became pregnant within three years, with roughly 40% of those conceiving naturally and the rest using assisted reproductive technology.²⁰ Since outcomes are better for milder stages, the prospects for people with Stage 2 are relatively favorable, though individual results depend on age, overall reproductive health, and other factors.

Does Stage 2 Always Get Worse Over Time?

One common fear after a Stage 2 diagnosis is that the disease will inevitably progress to more advanced stages. The evidence paints a more nuanced picture. A systematic review estimated that deep endometriotic lesions progressed in about 21% of untreated individuals, while progression dropped to about 12% with hormonal treatment.²¹ That review focused on deep endometriosis specifically, which is more relevant to Stage 3 and 4. For milder disease, the trajectory is even more variable.

A prospective study of women with deep pelvic endometriosis who chose to wait and watch found that about half stayed stable over the follow-up period, about a third progressed, and roughly 13% actually saw their disease regress on its own.²² Progression is real but not inevitable, and the percentage who stayed the same or improved was larger than the percentage who got worse. This is useful to know when weighing whether to start hormonal treatment primarily to prevent progression versus waiting to see how things go.

Overlapping Conditions That Complicate the Picture

If you have Stage 2 endometriosis and also deal with bloating, irregular bowel habits, or abdominal cramping that does not seem tied to your cycle, you are not imagining things. The overlap between endometriosis and irritable bowel syndrome is well documented. A meta-analysis found that the odds of having IBS were roughly three times higher in people with endometriosis compared to healthy controls, with a pooled IBS prevalence of about 23% among endometriosis patients.²³ In a large registry-based study, about 14% of women with endometriosis also had IBS, and about 9% of women with IBS also had endometriosis, both rates higher than in the general population.²⁴

The connection may go deeper than coincidence. Both conditions share a background of chronic low-grade inflammation, and some researchers believe they promote each other: the inflammatory state that sustains endometriosis may also sensitize the bowel, and vice versa.²⁵ This matters practically because IBS symptoms can be mistaken for worsening endometriosis, leading to unnecessary interventions, or the reverse: bowel-related endometriosis signs can be dismissed as “just IBS.” Getting both conditions properly identified can sharpen the treatment plan.

The Mental Health Dimension

Living with chronic pelvic pain, painful periods, and the uncertainty of a condition that may or may not progress takes a real psychological toll. Research consistently finds a link between endometriosis symptoms and mental health. A scoping review of quality-of-life studies reported moderate to strong correlations between endometriosis and both depressive and anxiety symptoms. People with endometriosis who also had mental health symptoms scored meaningfully worse on quality-of-life measures than those without them.²⁶

This is not a “Stage 4 problem.” The lack of correlation between stage and pain severity means people with Stage 2 can experience the same level of daily disruption, the same impact on work and relationships, and the same risk of depression and anxiety as those with more advanced disease. If anything, having a diagnosis labeled “mild” can add an extra layer of frustration when the experience is anything but mild, and when other people, including some clinicians, interpret the stage label to mean the symptoms should not be that bad.

Emerging Blood-Based Tests

Because the current diagnostic pathway often requires surgery, researchers are working hard on less invasive alternatives. One active area is circulating microRNAs, tiny molecules shed into the bloodstream that may differ between people with and without endometriosis. A recent study in an Indian population identified two microRNAs (miR-451a and miR-20a-5p) that were expressed at lower levels in endometriosis patients, with good diagnostic accuracy in the study sample.²⁷ Earlier work using a different set of three microRNAs managed to detect minimal-to-mild endometriosis with decent sensitivity in a discovery group, but when validated in a separate cohort, the specificity dropped considerably.²⁸

The bottom line on blood tests is that they are not ready for clinical use yet. Sensitivity, which measures how well a test catches true cases, has been promising in initial studies, but specificity, the ability to correctly rule out people who do not have the disease, keeps falling apart in validation. Still, the field is progressing, and a reliable blood-based screen could eventually shorten the years-long diagnostic journey that so many people with Stage 2 disease endure.

Anti-Inflammatory Supplements and Lifestyle

Given how central inflammation appears to be in both pain and fertility problems with endometriosis, interest in anti-inflammatory diets and supplements is high. A meta-analysis of randomized controlled trials found that anti-inflammatory dietary supplements could reduce pelvic pain in endometriosis, though the benefit was clearest in specific subgroups: participants aged 32 or older, those who supplemented for more than eight weeks, those taking anti-inflammatory vitamins specifically, and those with endometriosis beyond Stage 2.²⁹ For people with Stage 2 specifically, the evidence that supplements alone will meaningfully control pain is thin. They may help at the margins as part of a broader approach, but they are not a replacement for hormonal or surgical treatment when those are needed.

Exercise, stress management, pelvic floor physiotherapy, and dietary changes that reduce inflammatory load all come up regularly in patient communities and clinical guidance. There is biological plausibility for all of them, particularly pelvic floor work given the finding that pelvic floor tenderness contributes to dyspareunia even in mild-stage disease. The honest assessment is that none of these have the same weight of trial evidence behind them that hormonal therapy does, but many people find them helpful as complements rather than alternatives.